| Production, purification and availability of 211At: Near term steps towards global access Y Feng, MR Zalutsky Nuclear medicine and biology 100, 12-23, 2021 | 44 | 2021 |
| An improved 211At-labeled agent for PSMA-targeted α-therapy RC Mease, CM Kang, V Kumar, SR Banerjee, IL Minn, M Brummet, ... Journal of Nuclear Medicine 63 (2), 259-267, 2022 | 39 | 2022 |
| Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals AJ DeGraffenreid, Y Feng, CL Barnes, AR Ketring, CS Cutler, SS Jurisson Nuclear medicine and biology 43 (5), 288-295, 2016 | 38 | 2016 |
| Dithiol aryl arsenic compounds as potential diagnostic and therapeutic radiopharmaceuticals AJ DeGraffenreid, Y Feng, DE Wycoff, R Morrow, MD Phipps, CS Cutler, ... Inorganic Chemistry 55 (16), 8091-8098, 2016 | 27 | 2016 |
| Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent Y Feng, Z Zhou, D McDougald, RL Meshaw, G Vaidyanathan, ... Nuclear medicine and biology 92, 171-183, 2021 | 22 | 2021 |
| Chromatographic separation of germanium and arsenic for the production of high purity 77As MD Gott, AJ DeGraffenreid, Y Feng, MD Phipps, DE Wycoff, MF Embree, ... Journal of Chromatography A 1441, 68-74, 2016 | 22 | 2016 |
| Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers Y Feng, R Meshaw, D McDougald, Z Zhou, XG Zhao, SA Jannetti, ... Scientific Reports 12 (1), 3020, 2022 | 21 | 2022 |
| A trithiol bifunctional chelate for 72, 77As: A matched pair theranostic complex with high in vivo stability Y Feng, AJ DeGraffenreid, MD Phipps, TL Rold, NC Okoye, FA Gallazzi, ... Nuclear Medicine and Biology 61, 1-10, 2018 | 21 | 2018 |
| Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment Y Feng, TE Phelps, V Carroll, F Gallazzi, G Sieckman, TJ Hoffman, ... Dalton Transactions 46 (42), 14677-14690, 2017 | 17 | 2017 |
| Effective treatment of human breast carcinoma xenografts with single-dose 211At-labeled anti-HER2 single-domain antibody fragment Y Feng, R Meshaw, XG Zhao, S Jannetti, G Vaidyanathan, MR Zalutsky Journal of Nuclear Medicine 64 (1), 124-130, 2023 | 16 | 2023 |
| Evaluation of 72Se/72As generator and production of 72Se for supplying 72As as a potential PET imaging radionuclide Y Feng, MD Phipps, TE Phelps, NC Okoye, JE Baumeister, DE Wycoff, ... Applied Radiation and Isotopes 143, 113-122, 2019 | 13 | 2019 |
| Site-specific Radiohalogenation of a HER2-targeted single-domain antibody fragment using a Novel Residualizing Prosthetic agent Y Feng, SM Sarrett, RL Meshaw, G Vaidyanathan, MA Cornejo, BM Zeglis, ... Journal of medicinal chemistry 65 (22), 15358-15373, 2022 | 8 | 2022 |
| Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy Y Liu, Z Zhou, Y Feng, XG Zhao, G Vaidyanathan, MR Zalutsky, T Vo-Dinh International Journal of Nanomedicine, 7297-7305, 2021 | 7 | 2021 |
| A New, Second Generation Trithiol Bifunctional Chelate for 72,77As: Trithiol(b)-(Ser)2-RM2 F Najafi Khosroshahi, Y Feng, L Ma, S Manring, TL Rold, FA Gallazzi, ... Bioconjugate Chemistry 32 (7), 1364-1373, 2021 | 7 | 2021 |
| Trithiol compounds—tricky but valuable: the design and synthesis of ligands for stabilizing radioarsenic for radiopharmaceutical development Y Feng, SS Jurisson Strategies and Tactics in Organic Synthesis 14, 207-224, 2019 | 5 | 2019 |
| Arsenic-72, 77 as a matched pair radiopharmaceutical for imaging and radiotherapy Y Feng University of Missouri--Columbia, 2018 | 3 | 2018 |
| A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target AP Olson, L Ma, Y Feng, F Najafi Khosroshahi, SP Kelley, ... Inorganic chemistry 60 (20), 15223-15232, 2021 | 2 | 2021 |
| Therapeutic efficacy of single-dose iso-[211At] SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts Y Feng, S Jannetti, R Meshaw, G Vaidyanathan, M Zalutsky Journal of Nuclear Medicine 62 (supplement 1), 1484-1484, 2021 | 2 | 2021 |
| Synthesis, Characterization, and Radiolabelling of Trithiol Ligands with Arsenic-77 A DeGraffenreid, Y Feng, AR Ketring, C Barnes, CS Cutler, SS Jurisson JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 58, S58-S58, 2015 | 2 | 2015 |
| Synthesis and therapeutic evaluation of [211At] YF2: a next generation PSMA-targeted radiopharmaceutical Y Feng, R Meshaw, G Vaidyanathan, M Pomper, M Zalutsky Journal of Nuclear Medicine 64 (supplement 1), P130-P130, 2023 | 1 | 2023 |
